A combined miR-34a and arsenic trioxide nanodrug delivery system for synergistic inhibition of HCC progression after microwave ablation

A combined miR-34a and arsenic trioxide nanodrug delivery system for synergistic inhibition of HCC progression after microwave ablation

Abstract Background Microwave ablation (MWA) has become an alternative treatment for unresectable hepatocellular carcinoma (HCC), but it does not eliminate the risk of recurrence and metastasis after treatment. Recent studies have demonstrated that miR-34a presents decreased gene expression in resid...

Full description

Bibliographic Details
Main Authors: Jian Hu, Wenceng Pei, Zhenyou Jiang, Zihuang Li
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Cancer Nanotechnology
Subjects:
Hepatocellular carcinoma
Microwave ablation
Nanodrug delivery
Arsenic trioxide
miR-34a
Online Access:https://doi.org/10.1186/s12645-021-00105-8

Internet

https://doi.org/10.1186/s12645-021-00105-8

Similar Items